Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics

Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics

Abstract Background This study aimed to develop and validate an ultrasound radiomics model for distinguishing invasive ductal carcinoma (IDC) from ductal carcinoma in situ (DCIS) by combining intratumoral and peritumoral features. Methods Retrospective analysis was performed on 454 patients from Che...

Full description

Saved in:

Bibliographic Details
Main Authors:	Heng Zhang, Tong Zhao, Jiangyi Ding, Ziyi Wang, Nannan Cao, Sai Zhang, Kai Xie, Jiawei Sun, Liugang Gao, Xiaoqin Li, Xinye Ni
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	BioMedical Engineering OnLine
Subjects:	Radiomics Ultrasound Breast cancer Peritumoral features
Online Access:	https://doi.org/10.1186/s12938-024-01315-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intratumoral and peritumoral radiomics for forecasting microsatellite status in gastric cancer: a multicenter study
by: Yunzhou Xiao, et al.
Published: (2025-01-01)

MRI-based intratumoral and peritumoral radiomics for assessing deep myometrial invasion in patients with early-stage endometrioid adenocarcinoma
by: Jing Yang, et al.
Published: (2025-01-01)

Intratumoral and peritumoral radiomics using multi-phase contrast-enhanced CT for diagnosis of renal oncocytoma and chromophobe renal cell carcinoma: a multicenter retrospective study
by: Yongsong Ye, et al.
Published: (2025-02-01)

Integrating intratumoral and peritumoral radiomics with clinical risk factors for prognostic prediction in pancreatic ductal adenocarcinoma patients undergoing combined chemotherapy and HIFU ablation
by: Xuehui Zhang, et al.
Published: (2024-12-01)

The Clinical Study of Intratumoral and Peritumoral Radiomics Based on DCE-MRI for HER-2 Positive and Low Expression Prediction in Breast Cancer
by: Shang Y, et al.
Published: (2024-12-01)

Interpretable machine learning model for predicting clinically significant prostate cancer: integrating intratumoral and peritumoral radiomics with clinical and metabolic features
by: Wenjun Zhao, et al.
Published: (2024-12-01)

Prediction of soft tissue sarcoma grading using intratumoral habitats and a peritumoral radiomics nomogram: a multi-center preliminary study
by: Bo Wang, et al.
Published: (2024-12-01)

MRI-based machine learning radiomics for prediction of HER2 expression status in breast invasive ductal carcinoma
by: Hong-Jian Luo, et al.
Published: (2024-12-01)

The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinoma
by: Yeon-koo Kang, et al.
Published: (2024-11-01)

CT-based intratumoral and peritumoral radiomics nomogram to predict spread through air spaces in lung adenocarcinoma with diameter ≤ 3 cm: A multicenter study
by: Yangfan Su, et al.
Published: (2025-06-01)

Ductal Carcinoma In Situ of the Breast in Sclerosing Adenosis Mimicking Microinvasive Ductal Carcinoma: A Rare Case Report
by: Yu‐Kai Chang, et al.
Published: (2024-12-01)

Preoperative Prediction of Breast Cancer Histological Grade Using Intratumoral and Peritumoral Radiomics Features from T2WI and DWI MR Sequences
by: Guo Y, et al.
Published: (2024-12-01)

High-risk breast lesions: a combined intratumoral and peritumoral radiomics nomogram model to predict pathologic upgrade and reduce unnecessary surgical excision
by: Tingting Liao, et al.
Published: (2024-12-01)

Case Report: Ductal Carcinoma In Situ in the Male Breast
by: Joshua Chern, et al.
Published: (2012-01-01)

1H-MRS parameters in non-enhancing peritumoral regions can predict the recurrence of glioblastoma
by: Wenchao Lu, et al.
Published: (2024-11-01)

Ductal Carcinoma In Situ: What the Pathologist Needs to Know and Why
by: Anita Bane
Published: (2013-01-01)

Comparison of multiple machine learning models for predicting prognosis of pancreatic ductal adenocarcinoma based on contrast-enhanced CT radiomics and clinical features
by: Yue Huang, et al.
Published: (2024-11-01)

Outcomes of Tamoxifen Treatment Alone in Patients With Ductal Carcinoma In Situ or Atypical Ductal Hyperplasia Who Refused Surgery
by: Youngji Kwak, et al.
Published: (2024-01-01)

Exploration of the breast ductal carcinoma in situ signature and its prognostic implications
by: Jiao Zhang, et al.
Published: (2023-02-01)

Claudin and transmembrane receptor protein gene expressions are reversely correlated in peritumoral brain edema
by: Anwar Abuelrub, et al.
Published: (2024-08-01)

Adenomyoepithelioma with Ductal Carcinoma In Situ: A Case Report and Review of the Literature
by: Sanjay Warrier, et al.
Published: (2013-01-01)

More microinvasive foci in larger tumours of breast ductal carcinoma in situ
by: Xiao-Yang Chen, et al.
Published: (2023-08-01)

Intratumoral and peritumoral radiomics of MRI predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma
by: Jie Sun, et al.
Published: (2025-01-01)

Increased Breast Density Correlates with the Proliferation-Seeking Radiotracer Tc(V)-DMSA Uptake in Florid Epithelial Hyperplasia and in Mixed Ductal Carcinoma in Situ with Invasive Ductal Carcinoma but Not in Pure Invasive Ductal Carcinoma or in Mild Epithelial Hyperplasia
by: Vassilios Papantoniou, et al.
Published: (2011-09-01)

A Juvenile Female with Ductal Carcinoma In situ Arising from a Fibroadenoma
by: Wan-Yu Hung, et al.
Published: (2023-04-01)

NOTIFICATION: Is it Ductal Carcinoma in Situ with Microinvasion or “Ductogenesis”? The Role of Myoepithelial Cell Markers
by: The Breast Journal
Published: (2025-01-01)

Simultaneously acquired rSUV and rCBF of 18F-FDG/MRI in peritumoral brain zone can help to differentiate the grade of gliomas
by: Hong Qu, et al.
Published: (2023-09-01)

Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ
by: Marija Debeljak, et al.
Published: (2024-12-01)

From ductal carcinoma in situ to invasive breast cancer: the prognostic value of the extracellular microenvironment
by: Taylor S. Hulahan, et al.
Published: (2024-12-01)

A morphometric signature to identify ductal carcinoma in situ with a low risk of progression
by: Marcelo Sobral-Leite, et al.
Published: (2025-01-01)

Research progress of MRI-based radiomics in hepatocellular carcinoma
by: Xiao-Yun Xie, et al.
Published: (2025-02-01)

Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline
by: Muriel Brackstone, et al.
Published: (2024-12-01)

A Case Report on Ductal Carcinoma in situ Arising from Axillary Accessory Breast Tissue
by: Kyung Eun Lee, et al.
Published: (2025-01-01)

Radiomic nomograms in CT diagnosis of gall bladder carcinoma: a narrative review
by: Nirupam Konwar Baishya, et al.
Published: (2024-12-01)

A new subtype of papillary ductal carcinoma in situ with tall cell and reversed polarity morphology: a rare case report
by: Ruiqi Zhong, et al.
Published: (2024-12-01)

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma
by: Valentina Brancato, et al.
Published: (2024-12-01)

A Nationwide Cross-Sectional Survey of UK Breast Surgeons’ Views on the Management of Ductal Carcinoma In Situ
by: Gurdeep S. Mannu, et al.
Published: (2015-01-01)

Investigation of metabolic features of glioblastoma tissue and the peritumoral environment using targeted metabolomics screening by LC-MS/MS and gene network analysis
by: N. V. Basov, et al.
Published: (2025-01-01)

Is there a place for surgery in oligometastatic ductal carcinoma of the pancreatic head?
by: Vasiliy I. Egorov, et al.
Published: (2024-11-01)

Radiomics predicting immunohistochemical markers in primary hepatic carcinoma: Current status and challenges
by: Yunqing Yin, et al.
Published: (2024-12-01)